Clincosm LogoSign in Get a demo

kaposiform hemangioendothelioma

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemangioma, Kaposiform Hemangioendothelioma Trial in Shanghai (Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2))

Completed
  • Hemangioma
  • Kaposiform Hemangioendothelioma
  • Shanghai, China
    Children's Hospital of Fudan University
Jan 27, 2023

Kaposiform Hemangioendothelioma, Tufted Angioma, Superficial Vascular Anomalies Trial in Shanghai (Percutaneous sirolimus, Oral

Recruiting
  • Kaposiform Hemangioendothelioma
  • +3 more
  • Percutaneous sirolimus
  • Oral sirolimus
  • Shanghai, China
    Children's Hospital of Fudan University
Jan 9, 2023

Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)

Recruiting
  • Kaposiform Hemangioendothelioma
  • Kasabach-Merritt Syndrome
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Oct 21, 2022

Sirolimus on Immunizations During Treatment of Kaposiform

Recruiting
  • Kaposiform Hemangioendothelioma
    • Shanghai, Shanghai, China
      Children's Hospital of Fudan University
    Apr 22, 2022

    Kaposiform Hemangioendothelioma Trial in Chengdu (Sirolimus)

    Recruiting
    • Kaposiform Hemangioendothelioma
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Apr 6, 2022